![Hongying Wang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hongying Wang
Corporate Officer/Principal presso China Nuokang Bio-Pharmaceutical, Inc.
Profilo
Hongying Wang is a professional who has worked as an Executive Vice President at China Nuokang Bio-Pharmaceutical, Inc. since 2007.
Prior to this, she worked as a Technology Supervisor at Shenyang Lantian Group Xinbei Pharmaceutical Co., Ltd.
Ms. Wang holds an MBA from Northeastern University, which she received in 2006, and an undergraduate degree from Liaoning University, which she received in 1996.
Posizioni attive di Hongying Wang
Società | Posizione | Inizio |
---|---|---|
China Nuokang Bio-Pharmaceutical, Inc.
![]() China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Corporate Officer/Principal | 23/11/2009 |
Precedenti posizioni note di Hongying Wang
Società | Posizione | Fine |
---|---|---|
Shenyang Lantian Group Xinbei Pharmaceutical Co., Ltd. | Corporate Officer/Principal | - |
Formazione di Hongying Wang
Northeastern University | Masters Business Admin |
Liaoning University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
China Nuokang Bio-Pharmaceutical, Inc.
![]() China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Health Technology |
Shenyang Lantian Group Xinbei Pharmaceutical Co., Ltd. |
- Borsa valori
- Insiders
- Hongying Wang